Novartis Pharmaceuticals Corporation Select country Select business.The Japanese scandal over research using the Novartis blockbuster hypertension drug Diovan (valsartan) continues to widen.Tokyo, Japan, Jan 22, 2007 - - Novartis Pharma K.K. and Mochida Pharmaceutical Co., Ltd. today announced that the two companies have signed a contract.
Novartis Cardiovascular DrugsMedical university study in Kyoto manipulated data on blood pressure medicine Diovan.
Kyoto, Japan - The Japanese Health, Labor, and WelfareMinistry is currently investigating a potential a link between valsartan (Novartis) and skin eruptions that.Novartis is facing criminal charges in Japan over allegations that it failed to adequately oversee a former employee who allegedly manipulated clinical data.
FDA SymbolNovartis faces criminal charges in Japan for using falsified clinical data in ads for Diovan, its blood pressure drug, thus misleading Japanese doctors.
Pharma Archives - JAPANMARKT : JAPANMARKTSwiss drugmaker Novartis has overhauled management operations and sanctioned key staff in Japan following an investigation into manipulated Diovan blood pressure drug.The Diovan data scandal in Japan has spawned a criminal action against Novartis.
Novartis is facing a new scandal after an ex-employee was arrested last week following allegations of scientific misconduct.Novartis AG is a publicly traded Swiss holding company that operates through the Novartis Group.Valsartan is a medicine available in a number of countries worldwide.Patent protection for Co-Diovan is expected to expire in Japan. for psoriasis and psoriatic arthritis in Japan.
Medical Device Clinical Trials
... valsartan その他 の ブランド 名 diovan 製造元 novartis
Learn more about Novartis company history, areas of research and innovation, recent news and awards.Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
... shows the entrance of a Novartis production site in Nyon, SwitzerlandSwiss drug giant Novartis Pharmaceuticals cleaned house at its Japanese arm, disgusted by doctored studies, unreported health risks and a persistent.Japan files complaint against Novartis over Diovan Japan files complaint against Novartis Pharma for advertising of hypertension drug Diovan.Three new Novartis medicines approved in Japan for patients with Type 2 diabetes, high blood pressure and advanced kidney cancer.
... that allegedly used false data, according to the Japanese government
Japan’s health ministry sueing Novartis over ‘exaggerated ...The Japanese government plans to order a suspension of 15 days for the Novartis unit in Japan, accusing the drug maker of failing to report thousands of.
Novartis Vaccines LogoNovartis AG may have violated a Japanese law by promoting its Diovan hypertension medicine as a treatment for cutting stroke risks without sufficient.
... Diovan – Novartis’ blockbuster blood pressure drug. UltimatelIn the meantime, it has completely revamped the local management team.Novartis Receives Japanese Approval For Three New Medicines.Diovan - The latest news about Diovan from the WSJ Japan Real Time Blog.TOKYO Oct 3 Novartis AG said on Thursday it did not expect a scandal over the marketing of its Diovan blood pressure drug in Japan to have a significant.
Novartis Pharma’s hypertension drug Diovan (Asahi Shimbun file photo ...
Last month, Swiss pharmaceutical company Novartis AG issued an apology to the Japanese public after it was accused of manipulating data in trials of Diovan, according.